I am a little confused with regards to the structure of Kagome deal. The deal in a way technically allows Kagome to leverage TB’s US distribution network and sell its products without involving TBEL.
Also, does someone have any idea on what was the shareholding structure before Kagome deal? I believe it was held by PE players and Ashok Vasudevan/Meera Vasudevan and others – pg 3 of http://www.kagome.co.jp/company/news/n_pdf/140415002.pdf.
I understand that this structure would be to give exit to PE players. But in the process, have AV/MV also partially exited? Currently they own 30% – what was their holding pre Kagome deal? And why did they exit partially, if at all – cashing out for years of efforts, especially at a time when they are talking of start of the third innings??
I am not able to clearly understand what good this deal does for TBEL and how different it would have been for TBEL, even if this deal hadn’t happened.
Also, why still continue with this manufacturing (TBEL) and marketing structure (PBI) – why not merge the two? Wouldn’t that simplify a lot of issues. What am I missing here?